Tweets
Follow us @PLRI
Article in the Lancet, Early Online Publication, 11 October 2011. Background The aim of Avahan, the India AIDS Initiative, was to reduce HIV transmission in the general population through large-scale prevention interventions focused on high-risk groups. It was launched in 2003 in six states with a total population of 300 million and a high HIV burden. We assessed the population-level effect of the first phase of Avahan (2003—08).
The expansion of access to antiretroviral therapy for millions of persons living with HIV in low-income countries has been lauded by many. However, the investment in such programs has at the same time been criticized by others, who claim diversion of resources from HIV prevention efforts and from other important health threats in these same countries. Yet, the time is right to recommit to the goal Article in the Lancet, Early Online Publication, 11 October 2011. Background The aim of Avahan, the India AIDS Initiative, was to reduce HIV transmission in the general population through large-scale prevention interventions focused on high-risk
The following is an abstract about the potential benefits of a HIV vaccine. It mentions ‘risk compensation’ which means abandoning condoms. It points out that mathmatical modelling shows that a partially effective vaccine may lead to increased HIV among sex workers if sex workers are less able to persuade clients to use condoms. The same is true of Prep and microbicides. Since this will inevitably happen when clients find out about any technology or medicine that will be seen an alternative to condoms this is a very important piece of information for sex workers. The RV144 trial on the ALVAC/AIDSVAX candidate
Paulo Longo Research Initiative. Terms and Conditions